Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on May 1, 2025
Benevis Celebrates its 10th Annual Sharing Smiles Day Across 11 States, Providing Free Dental Care to Families in Need
GlobeNewswire
·
May 1, 2025
Atlanta, GA, May 01, 2025 (GLOBE NEWSWIRE) -- Benevis, a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, will proudly host its 10th annual Sharing Smiles Day in support of …
D'un océan à l'autre pour la guérison en appui à Percée DT1(MC) Canada
GlobeNewswire
·
May 1, 2025
Matt Varey, un membre du conseil d’administration de Percée DT1, traverse le Canada à vélo pour appuyer la recherche sur le diabète de type 1 TORONTO, 01 mai 2025 (GLOBE NEWSWIRE) -- À compter du 3 mai, Matt Varey, vice-président du conseil d' …
NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time
GlobeNewswire
·
May 1, 2025
EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …
Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
GlobeNewswire
·
May 1, 2025
TARRYTOWN, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its oncology and hematology portfolio will be shared at the 2025 American Society of Clinical Oncology (ASCO) Annual …
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain
GlobeNewswire
·
May 1, 2025
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses key learnings from initial trial phase (“POC 1”) where clinically meaningful pain reduction was demonstrated Outlines Company’s plans to initiate market expansion study (“POC 2”) into …
Celebrity Trainer Pieter Vodden Partners with Campio to Promote Daily Joint Support for Active Lifestyles
GlobeNewswire
·
May 1, 2025
PALOS VERDES ESTATES, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Campio, the supplement brand empowering consumers with confidence via validation from professional athletes, has now partnered with fitness expert and coach to the stars, Pieter Vodden. Vodden, …
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
GlobeNewswire
·
May 1, 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its AAV …
SRx Health Solutions to Consider Allocating Up to 10% of Future Cash Flows and Cash Reserves to Bitcoin, Solana and Gold
GlobeNewswire
·
May 1, 2025
TAMPA, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that it will explore an initiative to allocate up to 10% of future cash flows and …
Senti Bio Releases Virtual Investor “What This Means” Segment
GlobeNewswire
·
May 1, 2025
Kanya Rajangam, MD, PhD, President, Head of R…
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
GlobeNewswire
·
May 1, 2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da …
Talking About Mental Health: Dr. Jeffrey Borenstein and Brain & Behavior Research Foundation Encourage Open Conversations During Mental Health Awareness Month
GlobeNewswire
·
May 1, 2025
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In recognition of May as Mental Health Awareness Month, Dr. Jeffrey Borenstein, President and CEO of the Brain …
Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025
GlobeNewswire
·
May 1, 2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced that an abstract …
SPR Expands Access to the SPRINT® PNS System for Veterans with New Distribution Agreement with Veteran’s Health Medical Supply
GlobeNewswire
·
May 1, 2025
- National clinical review and contract offers an easier path to care for millions of Veterans - CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- SPR announced today that the SPRINT PNS System is now available on the Department of Veteran’s Affairs (VA) …
Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit
GlobeNewswire
·
May 1, 2025
PRINCETON, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeting the tumor microenvironment (TME), today announced it …
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
GlobeNewswire
·
May 1, 2025
Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through …
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
GlobeNewswire
·
May 1, 2025
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD data from the landmark Phase 3 trials will highlight …
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
GlobeNewswire
·
May 1, 2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled in the …
Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of…
GlobeNewswire
·
May 1, 2025
PALO ALTO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
GlobeNewswire
·
May 1, 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a pioneering brain–computer interface (BCI) company, today announced two significant additions to its senior leadership team. These appointments follow Precision’s …
Eleos Advances Comprehensive Behavioral Health Product Capabilities
GlobeNewswire
·
May 1, 2025
The new Eleos Documentation experience brings industry-leading augmented intelligence tools to more behavioral health use cases, 150+ languages, and rural or offline care settings Eleos dives deeper into Spring product updates and AI governance and …